Cargando…
A Case of Iliopsoas Hematoma Caused by Prophylactic Anticoagulation against COVID-19
BACKGROUND: COVID-19 is associated with an increased risk of venous thromboembolism (VTE), and prophylactic anticoagulation is recommended for the prevention of VTE in COVID-19 patients. We encountered a patient with COVID-19 who developed iliopsoas hematoma (IPH) that was likely caused by prophylac...
Autores principales: | Masaki, Shoichi, Takahashi, Tadashi, Sahara, Toshinori, Endo, Ryo, Obana, Masayoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JARM
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811153/ https://www.ncbi.nlm.nih.gov/pubmed/35178482 http://dx.doi.org/10.2490/prm.20220004 |
Ejemplares similares
-
Spontaneous Iliopsoas Hematoma: A Rare Complication of Anticoagulant Use
por: Kim, Sang Wha, et al.
Publicado: (2015) -
Ultrasound therapy in iliopsoas hematoma
por: Kaya, Basak Bilir, et al.
Publicado: (2017) -
Spontaneous iliopsoas hematoma with hip pain and ecchymosis of the thigh
por: Takahashi, Fumihiko
Publicado: (2019) -
Fatal retroperitoneal hematoma associated with Covid-19 prophylactic anticoagulation protocol
por: Teta, Michael, et al.
Publicado: (2021) -
Iliopsoas Hematomas in a Patient with Progressive Encephalomyelitis with Rigidity and Myoclonus
por: Shimazaki, Rui, et al.
Publicado: (2021)